This is because metabolic reprogramming in cancer cells or embryo/stem cells is often accompanied by many epigenetic alterations that require a large number of transcriptional regulators, that incidentally drive the upregulation of RBBP4/7. The gene discussed is RBBP4; the disease is cancer.